Description
Meroark-S 1.5 Injection is a powerful combination antibiotic formulated with Meropenem (1000mg) and Sulbactam (500mg). This dual-action composition is widely used in hospitals to treat severe and complicated bacterial infections. The presence of Meropenem, a broad-spectrum carbapenem antibiotic, ensures rapid bacterial elimination, while Sulbactam enhances its effectiveness by inhibiting resistance-causing enzymes.
This injection is commonly prescribed for conditions such as respiratory tract infections, intra-abdominal infections, urinary tract infections, skin infections, and septicemia. The combination works synergistically to combat multidrug-resistant bacteria, making it a preferred choice in critical care settings.
Key Benefits:
- Broad-spectrum antibacterial coverage
- Effective against resistant strains
- Rapid action in severe infections
- Trusted for hospital and ICU use
Usage & Administration:
Meroark-S 1.5 is administered intravenously under medical supervision. Dosage and duration depend on the severity of infection and the patient’s condition. It is essential to complete the full prescribed course to avoid resistance development.
Safety Information:
Patients should inform their doctor about allergies, kidney issues, or ongoing medications before use. Mild side effects may include nausea, diarrhea, or injection site reactions.
Conclusion:
Meroark-S 1.5 Injection stands out as a reliable and potent antibiotic solution for life-threatening infections. Its advanced formulation ensures effective bacterial control while reducing resistance risks, making it a critical component in modern antimicrobial therapy.
